Copper–zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma
Multiple myeloma (MM) is an incurable B-cell malignancy. The proteasome inhibitor bortezomib (BTZ) is a frontline MM drug; however, intrinsic or acquired resistance to BTZ remains a clinical hurdle. As BTZ induces oxidative stress in MM cells, we queried if altered redox homeostasis promotes BTZ res...
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Elsevier
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309843/ |